ORYZON Genomics

Oryzon develops and commercializes epigenetic therapies for the treatment of oncology and neurodegenerative diseases.

Business Model:

Revenue: $0

Employees: 11-50

Detailed ORYZON Genomics Information

Geographic Data

ORYZON Genomics headquarters map

Address: Calle Sant Ferrán 74

City: Cornellá de Llobregat

State: barcelona

Zip: 08940

Country: ES

Financial Info

Stage:

convertible note

Raised Last:

$21M

Raised Total:

$75M

Metrics

2,228,556Website Global Rank

8,629Website Monthly Traffic

Twitter Followers

Description

Oryzon develops and commercializes epigenetic therapies for the treatment of oncology and neurodegenerative diseases.

Contact Phone:

Contact Email:

ORYZON Genomics went public on 12/15/2015 on the BME Spanish Exchanges

Listed Exchange:
BME Spanish Exchanges

IPO Date:
12/15/2015

Ticker Symbol:
ORY

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2006 Funding Round - Grupo Ferrer Internacional
Grupo Ferrer Internacional
2/2003 Series A 1 $1.2M Najeti Capital
Najeti Capital
10/2018 Post-IPO Equity $14.8M
7/2022 Convertible Note 1 $20.5M Nice &a; Green SA
Nice &a; Green SA
7/2019 Post-IPO Equity $20M
1/2011 Grant 1 $300k Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
12/2018 Post-IPO Debt $1.1M
3/2008 Series B $0 Corsabe Capital
Laboratorios Ordesa
Corsabe Capital
Laboratorios Ordesa
3/2017 Post-IPO Equity $19.2M
9/2016 Post-IPO Debt $6M
7/2020 Post-IPO Equity $22.5M
12/2015 Post-IPO Debt $1.3M
10/2014 Grant $1.4M
4/2017 Grant 1 $300k Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
7/2019 IPO -
6/2022 Grant 1 $2M European Commission
European Commission
7/2019 Private Placement $22.3M
5/2016 Post-IPO Debt $12.1M
12/2016 Grant $800k
9/2021 Grant 1 $1M Kabuki Syndrome Foundation
Kabuki Syndrome Foundation
10/2018 Private Placement $14.8M
5/2019 Grant 1 $1.5M Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
5/2015 Grant 1 $270k Alzheimer&s;s Drug Discovery Foundation
Alzheimer&s;s Drug Discovery Foundation
12/2022 Grant 1 $423.9k European Union
European Union
1/2015 Venture Round 1 - ICF Capital
ICF Capital
10/2015 Series C $19M
7/2019 IPO -

Announced Date Name Price
3/2009 Crystax Pharmaceuticals

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research